Table 3.
Clinical response to reported events.
| Clinical response | Total (N=103), n (%) | Amber (n=88), n (%) | Red (n=15), n (%) |
| Heath care utilization required | 16 (15.5) | 7 (8.0) | 9 (60.0) |
| Hospitalization for device replacement | 7 (6.8) | 4 (4.5) | 3 (20.0) |
| Hospitalization for lead revision | 2 (1.9) | —a | 2 (13.3) |
| Hospitalization for cardiovascular reasons | 1 (1.0) | — | 1 (6.7) |
| In-office visit required | 6 (5.8) | 3 (3.4) | 3 (20.0) |
| Event resolved remotely | 87 (84.5) | 81 (92.0) | 6 (40.0) |
| New transmission required | 17 (16.5) | 11 (12.5) | 6 (40.0) |
| Not urgent actionb | 70 (68.0) | 70 (79.5) | — |
aNot applicable.
bEvent previously managed, monitoring the status of the event. The proportions are calculated on the total number of reported events (103, 88 amber, and 15 red).